Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 season

Trial Identifier: D2560C00009
Sponsor: MedImmune, LLC
Collaborator:
AstraZeneca
NCTID:: NCT02473510
Start Date: June 2015
Primary Completion Date: January 2016
Condition: Healthy Volunteers; Influenza Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
Spanish Translation

Trial Locations

Country Location
United States of America, FL South Miami, FL, United States of America
United States of America, GA Stockbridge, GA, United States of America
United States of America, OR Portland, OR, United States of America